<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(1)</volume><submitter>Xin W</submitter><funding>Outstanding Talent of Changzhou "The 14th Five-Year Plan" High-Level Health Talents Training Project</funding><funding>Changzhou Clinical Medical Center (Nuclear Medicine)</funding><funding>Clinical Medical Science and Technology High-end Platform and Transformation Base Construction Project of Soochow University (Characteristic Discipline)-Nuclear Medicine</funding><journal>BMC cancer</journal><pagination>1807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12641985</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tumor metabolic heterogeneity based on &amp;lt;sup&amp;gt;18&amp;lt;/sup&amp;gt;F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.</pubmed_title><pmcid>PMC12641985</pmcid><funding_grant_id>CZZX202204, PI: Yuetao Wang</funding_grant_id><funding_grant_id>PI: Yuetao Wang</funding_grant_id><funding_grant_id>2022-260, PI: Yuetao Wang</funding_grant_id><pubmed_authors>Lu L</pubmed_authors><pubmed_authors>Zang H</pubmed_authors><pubmed_authors>Gu W</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Xin W</pubmed_authors><pubmed_authors>He B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tumor metabolic heterogeneity based on &amp;lt;sup&amp;gt;18&amp;lt;/sup&amp;gt;F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T19:34:29.313Z</modification><creation>2026-05-21T03:09:14.427Z</creation></dates><accession>S-EPMC12641985</accession><cross_references><pubmed>41286784</pubmed><doi>10.1186/s12885-025-15149-x</doi></cross_references></HashMap>